Skip to main content
Article thumbnail
Location of Repository

Pharmacokinetics and pharmacodynamics of: 1) Oral sustained release acetaminophen suspension in children; 2) Potassium chloride in adults



Graduation date: 199

Year: 1993
OAI identifier:
Provided by: ScholarsArchive@OSU

Suggested articles


  1. (1992). Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol.
  2. (1987). Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet.
  3. (1991). Kinetics of acetaminophen after single and multiple dose oral administration as a gradient matrix system to healthy male subjects.
  4. (1991). Comparison of in vitro and in vivo release characteristics of acetmainophen from gradient matrix systems.
  5. (1989). Single dose bioavailabilty of acetaminophen following oral administration.
  6. (1982). In vitro-in vivo correlation, a time scaling problem?
  7. (1990). Altered Hepatobiliary Disposition of Acetaminophen Metabolites After Phenobarbital Pretreatment and Renal Ligation: Evidence for Impaired Biliary Excretion and a Diffusional Barrier.
  8. (1992). Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children.
  9. (1989). Acetaminophen: More harm than good for chicken pox?.
  10. (1989). Immediate adverse reactions to acetaminophen in children: Evaluation of histamine release and spirometry.
  11. (1986). Inhibitors of protein and RNA synthesis cause a rapid block in prostaglandin production at the prostaglandin synthase step.
  12. (1990). Estimation of the in vivo effect of cyclooxygenase inhibitors on prostaglandin E2 levels in mouse brain.
  13. (1982). Clinical pharmacokinetics of paracetamol.
  14. (1985). A polyexponential deconvolution method. evaluation of the "gastrointestinal bioavailabilty" and mean in vivo dissolution time of some ibuprofen dosage forms.
  15. (1990). Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers.
  16. (1987). Underdosing of acetaminophen by parents.
  17. (1990). Variables that influence coat integrity in a laboratory spray coater.
  18. (1992). Pharmacokinetics and pharmacodynamics in the design of controlled-release beads with acetaminophen as model drug.
  19. (1988). In vitro-in vivo correlation exemplified by sustained release formulations of suprofen.
  20. (1992). Antipyretic efficacy of ibuprofen vs acetaminophen.
  21. (1961). Stabilty of aqueous solution of N-Acetyl-p-aminophenol,
  22. (1985). Parental fever phobia and its correlates.
  23. (1991). Design and evaluation of sustained-release tablets of lithium in a fat matrix and its bioavailability in humans.
  24. (1972). Linearization of dissolution rate curves by the Weibull distribution.
  25. (1990). New acetaminophen products: Formulation development and bioavailability. Ph.D thesis,
  26. (1989). Factors affecting acetaminophen release from polymer coated beads.
  27. (1989). Effect of multiple polymer film layers on acetaminophen release,
  28. (1989). Temperature response to acetaminophen and risk of occult bacteremia: A case-control study.
  29. (1975). Hyperpyrexia in children: Eight year emergency room experience.
  30. (1955). The acute response to potassium ingestion.
  31. (1992). Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo-controlled evaluation using painful laser stimulation.
  32. (1991). A comparison of the hypoalgesic effect of paracetamol in slow-release and plain tablets on laser-induced pain.
  33. (1990). In vitro and in vivo characterisation of two sustained release formulations for the antidepressant Rolipram.
  34. (1985). Effects of KCL infusion on potassium excretion in sheep.
  35. (1978). Acetaminophen overdose: Incidence, diagnosis, and management in 416 patients.
  36. (1980). Fever phobia.
  37. (1991). A comparison of serum and saliva paracetamol concentrations.
  38. (1987). New product formulation and multiple dose pharmacokinetics of acetaminophen.
  39. (1989). Prostaglandin formation in the hypothalamus in vivo: Effect of pyrogens.
  40. (1975). Increased viral shedding with aspirin treatment of rhinovirus infection.
  41. (1983). Pediatric dosing of acetaminophen.
  42. (1983). Review of comparitive antipyretic activity in children.
  43. (1985). Pharmaockinetics of potassium cholride in wax-based syrup formulations.
  44. (1991). USP Subcommittee on Dissolution and Bioavailability. In vitro and in vivo evaluation of dosage forms,
  45. (1989). and placebo treatment of febrile children.
  46. (1987). Fever response to acetaminophen in viral vs. bacterial infections.
  47. (1991). placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children.
  48. (1988). Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester.
  49. (1991). Aspirin inhibits interleukin-1 induced prostaglandin H synthase expression in cultured endothelial cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.